Adjuvant therapy after mastectomy is needed in all of the following except:
**Core Concept**
Adjuvant therapy after mastectomy is a treatment approach aimed at reducing the risk of cancer recurrence by targeting remaining cancer cells and the microenvironment. This type of therapy is often used in conjunction with surgery to improve outcomes for patients with breast cancer.
**Why the Correct Answer is Right**
Adjuvant therapy can take various forms, including chemotherapy, hormone therapy, targeted therapy, and radiation therapy. The decision to use adjuvant therapy depends on several factors, including the stage and grade of the cancer, the type of breast cancer, and the patient's overall health. For instance, patients with hormone receptor-positive breast cancer may benefit from hormone therapy to reduce the risk of recurrence.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because adjuvant therapy is often necessary for patients with lymph node-positive breast cancer to reduce the risk of recurrence.
**Option B:** This option is incorrect because adjuvant therapy is not typically needed for patients with ductal carcinoma in situ (DCIS), as it is a non-invasive form of cancer.
**Option C:** This option is incorrect because adjuvant therapy is often necessary for patients with stage II or III breast cancer to reduce the risk of recurrence.
**Clinical Pearl / High-Yield Fact**
It's essential to note that the decision to use adjuvant therapy should be individualized and based on a thorough evaluation of the patient's cancer, medical history, and personal preferences.
**Correct Answer: B. Ductal carcinoma in situ (DCIS) does not require adjuvant therapy after mastectomy.**